Sarepta Therapeutics
SRPT
SRPT
151 hedge funds and large institutions have $1.1B invested in Sarepta Therapeutics in 2015 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 67 increasing their positions, 38 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
16% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 19
1% more funds holding
Funds holding: 149 → 151 (+2)
Holders
151
Holding in Top 10
3
Calls
$184M
Puts
$99.4M
Top Buyers
| 1 | +$56.5M | |
| 2 | +$26.6M | |
| 3 | +$25.1M | |
| 4 |
Millennium Management
New York
|
+$15.9M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$11.3M |
Top Sellers
| 1 | -$37.4M | |
| 2 | -$22.6M | |
| 3 | -$21M | |
| 4 |
D.E. Shaw & Co
New York
|
-$14.2M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$12.6M |